First Description of Novel End-Organ Effects by Speed Modulation Using the Aortix™ Device
Case Reports in Cardiology · 2024-04-24 · 2024 · 1-6
DOI: 10.1155/2024/7430212 ↗Abstract
Aortix™ is a novel percutaneous mechanical circulatory support device designed to facilitate diuresis in patients with cardiorenal syndrome. We describe for the first time the development of end-organ hypoperfusion from excess blood acceleration at the nominal setting and demonstrate through temporal-perfusion marker curves, the potential for speed modulation to optimize results. This will inform future device development and investigation of patient-specific device titration.
EUVIMED